Tag Archives: https://www.uspto.gov/

Regeneus, a clinical-stage regenerative medicine company, today announced that the United States Patent Office has issued a notice of allowance for issuance of a patent covering the composition and use of Progenza. Issuance of the patent for United...

Read More »